10x Genomics (TXG) shares climbed roughly 44% over the last 30 days, rising from about $62.45 to $90.04 as of the most recent close. The advance extends a powerful multi-month rally, with the stock more than doubling over the last quarter.

Iovance Biotherapeutics (IOVA) shares rose roughly 77% over the past 30 days, climbing from about $8.17 to $14.45 per share. The rally was powered by a raised full-year 2026 revenue outlook, driven by strong demand for Amtagvi and Proleukin.

UiPath shares declined roughly 34% over the trailing 30 days, from a closing price of $18.67 on August 31 to $12.32 as of the September 29 close. The selloff began after the company's fiscal Q2 2027 results on September 3, which topped revenue estimates but guided to a notable slowdown in third-quarter growth.

MongoDB (MDB) shares fell roughly 26% over the trailing 30 days, sliding from about $453 on August 31 to around $337 by September 29. The move was triggered by the abrupt departure of CEO Chirantan "CJ" Desai to lead a new enterprise unit at Meta Platforms , driving an 18% single-day plunge on September 28.

Booking Holdings shares fell roughly 18.5% over the trailing 30 days, from a closing price of $199.09 on August 31, 2026, to $162.34 on September 29, 2026. The decline was driven by an EU court ruling upholding the block on its eTraveli acquisition, AI-agent disruption fears tied to Meta's Muse, and a rise in oil prices.

AMDL, a leveraged single-stock exchange-traded fund (ETF) that targets 2x (200%) the daily return of AMD , climbed roughly 67% over the trailing 30 days. The fund's entire exposure is concentrated in the semiconductor industry, with 100% of its sector allocation in technology.

MSTY climbed roughly 28% over the last 30 days, recovering from about $11.93 to $15.23 as its underlying single-stock exposure rebounded sharply. The move tracked a powerful recovery in MSTR (Strategy Inc.), the bitcoin treasury company that the fund's synthetic covered call strategy is built around.

United States Oil Fund (USO) climbed roughly +24% over the last 30 days, reflecting a sharp rally in crude oil prices. Over the trailing quarter, the fund gained approximately +29% , extending a broader multi-month uptrend in energy markets.

SNXX, the Tradr 2X Long SNDK Daily ETF, rose roughly +15% over the trailing 30 days as its sole underlying holding, SanDisk, rebounded from late-summer lows. Over the trailing quarter, SNXX fell about -61% , reflecting a sharp July drawdown in memory stocks amplified by the fund's 2x daily leverage.

ETHU is a leveraged, daily-reset exchange-traded fund (ETF) that targets two times (2x) the daily price performance of Ether, the native asset of the Ethereum network. The fund advanced roughly 14% over the last 30 days and more than tripled over the past quarter, reflecting a strong Ether rally amplified by daily leverage.

XRPN (Armada Acquisition Corp. II) jumped +25.14% during regular trading hours on Sept 29, climbing from a $10.58 prior close to $13.24. The catalyst is the Sept 30 special shareholder vote on the merger with Evernorth, which would bring a managed XRP treasury (~473M XRP) onto Nasdaq under the XRPN ticker.

IDT shares surged +10.51% during regular trading, climbing from a $69.56 prior close to roughly $76.87. Primary catalyst: record fourth-quarter and full-year fiscal 2026 results reported after Monday's close, plus upbeat fiscal 2027 guidance.

Different scale and sector focus: ARAY is a radiation therapy equipment maker, while ILMN is a genomics and DNA-sequencing leader. Diverging momentum: Illumina is in a strong uptrend with accelerating revenue growth, while Accuray is managing a revenue decline and a balance-sheet turnaround.

Both are speculative, small-cap biotech/pharma names trading on the Nasdaq with sub-$1-to-low-single-digit share prices and elevated volatility. FLNA is a clinical-stage developer of CNS (central nervous system) therapies that has faced an FDA clinical hold and a Nasdaq listing-compliance notice.

APUS is an early-stage company that has recently pivoted toward digital-asset (bitcoin treasury) operations, while DERM is a commercial-stage dermatology pharmaceutical company with marketed, revenue-generating products. DERM generates recurring revenue from eight branded, FDA (U.S. Food and Drug Administration)-approved drugs; APUS reported no biopharmaceutical revenue and disclosed a going-concern risk in its most recent annual filing.

SMX shares have fallen roughly 57% over the past 30 days, declining from about $16.61 (closing level on August 28) to about $7.22, as selling accelerated sharply in late September. The stock is down approximately 47% over the trailing three-month period, extending a longer pattern of decline for this micro-cap, Nasdaq-listed company.

DELL is levered to the AI-server build-out, with a record backlog and sharply raised revenue guidance; NTAP offers steadier, higher-margin exposure to data storage and cloud. DELL is growing much faster on the top line but carries a lower margin profile and higher debt; NTAP grows more slowly but is highly profitable and returns substantial cash to shareholders.

EVGN is trading up +10.42% intraday (to roughly $0.42), rebounding during the regular session from a prior close of $0.38. The gain follows yesterday's -8.59% post-earnings selloff after Q2 2026 results reported EPS of -$0.63 and revenue down 76.4% year-over-year to $670K.

KMRK climbed +15.05% to roughly $1.07 in regular-session trading, up from a prior close near $0.93. The move occurred during normal market hours, not premarket or after-hours.

DXST is trading up +64.62% during regular market hours, around $3.21 versus a prior close of $1.95. The move follows an overnight after-hours spike of roughly +148% to about $3.97, triggered by an SEC filing revealing Chairman Dingxin Sun raised his voting stake to 90.5% through a private placement.